SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Transdermal Drug Patches to 2020

NEW YORK, Jan. 22, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Transdermal Drug Patches to 2020

http://www.reportlinker.com/p01941669/Transdermal-Drug-Patches-to-2020.h...

Greystone Research Associates is pleased to announce the publication of a new market study. Transdermal Drug Patches to 2020: Products, Therapeutics, Markets, and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, patch designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for Transdermal patches Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Wearable Drug Systems and the Growth of Chronic Disease Management

Considered by many to be a niche delivery technology, transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2020.

Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2020.

Feature Summary

- Analyzes and evaluates current transdermal drug patch markets and products and assesses the market potential for existing and probable future products - Analyzes patch designs, technologies and patch development issues - Profiles patch manufacturers and third-party transdermal supply chain companies - Provides detailed assessments of more than forty patch products in more than a dozen product categories - Provides market data and forecasts to 2020 - Profiles transdermal drug patch product providers, their product development activity, and strategies - Evaluates the impact of economic, technology, and regulatory factors

Highlights

- Analyzes and evaluates prescription skin patch products and assesses risks and market potential

- Analyzes patch designs, technologies and patch development issues

- Provides assessments of transdermal drug patch products in two dozen key market segments

- Provides market data and forecasts to 2020

- Profiles patch manufacturers, their product development activities and strategies

Executive Summary

The Market Opportunity

Transdermal Drug Delivery Dynamics

Demand Drivers

Competitive Landscape

Factors Limiting Growth

Pharmacokinetics & Dosage Forms

Patch Manufacturing Dynamics

Patch Manufacturing Company Profiles

Product Analysis – FDA-Approved Drugs Delivered via Transdermal Patches

Alkaloids

Androgens

Antidepressants

Antiemetics

Antispasmodics

CNS Stimulants

Cholinesterase Inhibitors

Dopamine Agonists

Hormone Replacement

Hypotensive Agents

Local Anesthetics

NSAIDs

Opioid Analgesics

Progestrins

Trinitrates

Market Analysis – Transdermal Drug Patch Therapeutics

ADHD

Addiction

Contraception

Cardiovascular/Angina

Depression

Hormone Replacement Therapy

Hypertension

Motion Sickness

Neurology

Osteoporosis

Pain Management

Market Factors

Regulatory Issues

IP and Expiring Patents

Rx-to-OTC Switching

Patient Compliance and Ease of Use

Healthcare Economics

Profiles of Market Participants

To order this report: Transdermal Drug Patches to 2020 http://www.reportlinker.com/p01941669/Transdermal-Drug-Patches-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.